Association of lipid-lowering drugs with risk of sarcopenia: a drug target mendelian randomization study and meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Association of lipid-lowering drugs with risk of sarcopenia: a drug target mendelian randomization study and meta-analysis ; volume:18 ; number:1 ; day:3 ; month:7 ; year:2024 ; pages:1-12 ; date:12.2024
Human genomics ; 18, Heft 1 (3.7.2024), 1-12, 12.2024
- Creator
-
Li, Jiaxin
Zang, Chenyang
Lv, Hui
Xiao, Zheng
Li, Peihong
Xiao, Bo
Zhou, Luo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40246-024-00643-3
- URN
-
urn:nbn:de:101:1-2409231213109.929194819146
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Li, Jiaxin
- Zang, Chenyang
- Lv, Hui
- Xiao, Zheng
- Li, Peihong
- Xiao, Bo
- Zhou, Luo
- SpringerLink (Online service)
Other Objects (12)
Causal relationship between PCSK9 inhibitor and autoimmune diseases: a drug target Mendelian randomization study
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation
Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
Correlations between genetically predicted lipid-lowering drug targets and inflammatory bowel disease
Nanotechnology-based delivery systems to overcome drug resistance in cancer
Causal relationship between lipid-lowering drugs and ovarian cancer, cervical cancer: a drug target mendelian randomization study
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Effective policy initiatives to constrain lipid-lowering drug expenditure growth in South Korea
Metabolomics approach reveals effects of antihypertensives and lipid-lowering drugs on the human metabolism
Lipid-lowering drugs and risk of rapid renal function decline: a mendelian randomization study
Causal relationship between PCSK9 inhibitor and autoimmune diseases: a drug target Mendelian randomization study
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation
Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
Correlations between genetically predicted lipid-lowering drug targets and inflammatory bowel disease
Nanotechnology-based delivery systems to overcome drug resistance in cancer
Causal relationship between lipid-lowering drugs and ovarian cancer, cervical cancer: a drug target mendelian randomization study
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Effective policy initiatives to constrain lipid-lowering drug expenditure growth in South Korea
Metabolomics approach reveals effects of antihypertensives and lipid-lowering drugs on the human metabolism
Lipid-lowering drugs and risk of rapid renal function decline: a mendelian randomization study
Causal relationship between PCSK9 inhibitor and autoimmune diseases: a drug target Mendelian randomization study
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation
Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
Correlations between genetically predicted lipid-lowering drug targets and inflammatory bowel disease
Nanotechnology-based delivery systems to overcome drug resistance in cancer
Causal relationship between lipid-lowering drugs and ovarian cancer, cervical cancer: a drug target mendelian randomization study
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Effective policy initiatives to constrain lipid-lowering drug expenditure growth in South Korea
Metabolomics approach reveals effects of antihypertensives and lipid-lowering drugs on the human metabolism